APA

Gheorghiade M., Orlandi C., Burnett J. C., Demets D., Grinfeld L., Maggioni A., Swedberg K., Udelson J. E., Zannad F., Zimmer C. & Konstam M. A. (20050913). Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST). : Journal of cardiac failure.

Chicago

Gheorghiade Mihai, Orlandi Cesare, Burnett John C, Demets David, Grinfeld Liliana, Maggioni Aldo, Swedberg Karl, Udelson James E, Zannad Faiez, Zimmer Christopher and Konstam Marvin A. 20050913. Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST). : Journal of cardiac failure.

Harvard

Gheorghiade M., Orlandi C., Burnett J. C., Demets D., Grinfeld L., Maggioni A., Swedberg K., Udelson J. E., Zannad F., Zimmer C. and Konstam M. A. (20050913). Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST). : Journal of cardiac failure.

MLA

Gheorghiade Mihai, Orlandi Cesare, Burnett John C, Demets David, Grinfeld Liliana, Maggioni Aldo, Swedberg Karl, Udelson James E, Zannad Faiez, Zimmer Christopher and Konstam Marvin A. Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST). : Journal of cardiac failure. 20050913.